<DOC>
	<DOCNO>NCT01344083</DOCNO>
	<brief_summary>The aim study compare efficacy safety T1210 versus Olopatadine eye drop topical treatment seasonal allergic conjunctivitis .</brief_summary>
	<brief_title>Comparison Efficacy Tolerability T1210 Olopatadine Hydrochloride 0.1 % Treatment Seasonal Allergic Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<criteria>Written inform consent Conjunctivitis allergic conjunctivitis Severe ocular allergy Vernal keratoconjunctivitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>